NEC BIRMINGHAM
27-28 NOVEMBER 2024

Loading

Insights to recently published evidence of individuals living with Fibromyalgia Syndrome using the Exopulse Mollii Suit

27 Nov 2024
Showcase Theatre
Insights to recently published evidence of individuals living with Fibromyalgia Syndrome using the Exopulse Mollii Suit

Fibromyalgia is a symptom complex heavily characterized by chronic pain as well as other symptoms as e.g. fatigue, sleep disorder, depression/anxiety. Multisite, non-invasive neuromodulation enlarges non-pharmacological treatment options and has the potential to:

  • Significantly reduce pain
  • Increase the Quality of Life
  • Improve depression and disease-related limitations
Speakers
Susanne Seidlinger, Senior Global Market Access & Health Economic Research Manager - OTTOBOCK

Education partner

  

Partner

  

Partner

  

Media Partner

  

Organised by

  

Partner

  

Educational Partner


 

Partner


 

Partner


 

Partner


 

Media Partner


 

Newsletter Sign-up


Be the first to hear the latest news, programme updates and exclusive industry releases.